Page last updated: 2024-10-22

amitriptyline and Atrioventricular Conduction Block

amitriptyline has been researched along with Atrioventricular Conduction Block in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Research Excerpts

ExcerptRelevanceReference
"The nortriptyline concentration was significantly associated with the QRS interval (pā€‰=ā€‰0."1.56Nortriptyline serum concentration as a predictor for cardiac risk in amitriptyline-treated patients. ( Deckert, J; Hommers, L; Menke, A; Scherf-Clavel, M; Unterecker, S; Zebner, J, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Scherf-Clavel, M1
Zebner, J1
Hommers, L1
Deckert, J1
Menke, A1
Unterecker, S1

Other Studies

1 other study available for amitriptyline and Atrioventricular Conduction Block

ArticleYear
Nortriptyline serum concentration as a predictor for cardiac risk in amitriptyline-treated patients.
    European journal of clinical pharmacology, 2020, Volume: 76, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Amitriptyline; Antidepressive Agents, Tricyclic; Atrioventricular Bl

2020